Literature DB >> 27464912

Insufficient Lymph Node Sampling in Patients with Colorectal Cancer Perforation is Associated with an Adverse Oncological Outcome.

Kotaro Sugawara1, Yoshikuni Kawaguchi2,3, Yukihiro Nomura1, Daisuke Koike1, Motoki Nagai1, Nobutaka Tanaka4.   

Abstract

BACKGROUND: The impact of lymph node (LN) dissection on long-term outcomes for patients with colorectal cancer (CRC) perforation remains unclear. We aim to investigate factors associated with poor prognosis and recurrence in patients with CRC, with special reference to cancer perforation and LN dissection.
METHODS: The subjects comprised 550 patients who underwent colorectal surgery for CRC at Stage II or III (TNM classification) between February 2006 and November 2013. Short- and long-term outcomes of patients with or without CRC perforation were evaluated. We also sought risk factors on poor prognosis, focusing on LN dissection in patients with CRC perforation.
RESULTS: A total of 508 underwent surgery for CRC without perforation (the non-perforation group) and 39 for CRC with perforation (the perforation group). Both overall survival and recurrence-free survival rates were significantly lower in the perforation group than in the non-perforation group (overall survival, P = 0.009; recurrence-free survival, P < 0.001). The relapse rates at the peritoneum (P = 0.002), lung (P = 0.007) and LNs (P = 0.021) were significantly higher in the perforation group than in the non-perforation group. Multivariable Cox proportional hazards model revealed that CRC perforation (hazard ratio [HR] 2.55, 95 % confidential interval [CI] 1.16-4.98, P = 0.022), LN dissection <12 (HR 1.83, 95 % CI 1.07-3.13, P = 0.027), and Stage III (HR 1.79, 95 % CI 1.06-3.08, P = 0.031) were significant and independent risk factors for poor prognosis.
CONCLUSIONS: Conducting <12 LN dissections independently increased the risk of reduction in overall survival for patients with CRC perforation. Thus, radical LN dissections should be performed to improve patients' survival rates, when patients' general and surgical conditions allow.

Entities:  

Mesh:

Year:  2017        PMID: 27464912     DOI: 10.1007/s00268-016-3667-y

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  26 in total

1.  Acute colonic perforation associated with colorectal cancer.

Authors:  S Khan; S E Pawlak; J C Eggenberger; C S Lee; E J Szilagy; D A Margolin
Journal:  Am Surg       Date:  2001-03       Impact factor: 0.688

2.  Obstruction and perforation in colorectal adenocarcinoma: an analysis of prognosis and current trends.

Authors:  H S Chen; S M Sheen-Chen
Journal:  Surgery       Date:  2000-04       Impact factor: 3.982

3.  High-risk groups of patients with Stage II colon carcinoma.

Authors:  S Merkel; A Wein; K Günther; T Papadopoulos; W Hohenberger; P Hermanek
Journal:  Cancer       Date:  2001-09-15       Impact factor: 6.860

4.  Outcome after emergency surgery for cancer of the large intestine.

Authors:  N S Runkel; P Schlag; V Schwarz; C Herfarth
Journal:  Br J Surg       Date:  1991-02       Impact factor: 6.939

5.  Perforated colorectal carcinomas.

Authors:  N Mandava; S Kumar; W F Pizzi; I J Aprile
Journal:  Am J Surg       Date:  1996-09       Impact factor: 2.565

6.  The effect of obstruction and perforation on colorectal cancer disease-free survival.

Authors:  Yik-Hong Ho; Simon K K Siu; Petra Buttner; Andrew Stevenson; John Lumley; Russel Stitz
Journal:  World J Surg       Date:  2010-05       Impact factor: 3.352

7.  Outcome of large-bowel perforation in patients with colorectal cancer.

Authors:  P G Carraro; M Segala; C Orlotti; G Tiberio
Journal:  Dis Colon Rectum       Date:  1998-11       Impact factor: 4.585

Review 8.  Adjuvant therapy for stage II colon cancer: an elephant in the living room?

Authors:  A Zaniboni; R Labianca
Journal:  Ann Oncol       Date:  2004-09       Impact factor: 32.976

9.  Risk factors for local recurrence of middle and lower rectal carcinoma after curative resection.

Authors:  Ze-Yu Wu; Jin Wan; Gang Zhao; Lin Peng; Jia-Lin Du; Yuan Yao; Quan-Fang Liu; Hua-Huan Lin
Journal:  World J Gastroenterol       Date:  2008-08-14       Impact factor: 5.742

10.  Identification of patients with high-risk stage II colon cancer for adjuvant therapy.

Authors:  Hak-Mien Quah; Joanne F Chou; Mithat Gonen; Jinru Shia; Deborah Schrag; Ron G Landmann; José G Guillem; Philip B Paty; Larissa K Temple; W Douglas Wong; Martin R Weiser
Journal:  Dis Colon Rectum       Date:  2008-03-06       Impact factor: 4.585

View more
  2 in total

1.  Postoperative Complications Predict Long-term Outcome After Curative Resection for Perforated Colorectal Cancer.

Authors:  Shintaro Hashimoto; Kiyoaki Hamada; Yorihisa Sumida; Masato Araki; Kouki Wakata; Tota Kugiyama; Ayako Shibuya; Masato Nishimuta; Shigeyuki Morino; Masayuki Baba; Soichiro Kiya; Keisuke Ozeki; Akihiro Nakamura
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

2.  Oncologic outcome of colon cancer with perforation and obstruction.

Authors:  Kwan Mo Yang; Min-Jae Jeong; Kwang Hyun Yoon; Yun Tae Jung; Jae Young Kwak
Journal:  BMC Gastroenterol       Date:  2022-05-15       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.